VR Adviser’s 89bio ETNB Stock Holding History

VR Adviser’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-291,140	Closed	-$5.8M	–	25
2020 Q2	$5.8M	Sell	291,140 -661,060	-69%	-$16.1M	1.39%	15
2020 Q1	$24M	Buy	+952,200	New	+$27.8M	6.51%	5

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

VR Adviser's ETNB Position: Q3 2020 in Review

VR Adviser sold out of 89bio (ETNB) in Q3 2020, closing a stake of 291,140 shares — an estimated $5.8M sold.

VR Adviser first reported a position in ETNB in Q1 2020 and held it in 2 quarters. The position peaked at $24M in Q1 2020. 68 funds tracked by Wall St. Rank hold ETNB as of Q3 2020.

VR Adviser reported no remaining 89bio position as of Q3 2020 after selling out during the quarter.
VR Adviser sold 291,140 89bio shares in Q3 2020, an estimated $5.8M.
VR Adviser first reported a position in 89bio in Q1 2020 and held it in 2 quarters.
VR Adviser's 89bio position peaked at $24M in Q1 2020.
68 funds tracked by Wall St. Rank held 89bio as of Q3 2020.

Based on VR Adviser's 13F filing for Q3 2020, filed 16 Nov 2020.